Monographie - Tirofiban - Stabilis 4.0

Poslední aktualizace :
08/05/2024

Antikoaguliantas

Tirofiban

Įpurškimas

Tirpalų stabilumas

Mišinių stabilumas

Stabilumą lemiantys veiksniai

Suderinamumas

Leidimo būdai

Bibliografija

Pdf

Prekinis pavadinimas

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Aggrastat	Airija, Australija, Austrija, Belgija, Danija, Didžioji Britanija, Iranas, Italija, Jungtinės Amerikos Valstijos, Jungtiniai Arabų Emyratai, Kanada, Lenkija, Liuksemburgas, Malaizija, Naujojoje Zelandijoje, Norvegija, Olandija, Portugalija, Saudo Arabija, Suomija, Švedija, Šveicarija, Turkija, Vengrija, Vokietija
Agrastat	Argentina, Brazilija, Čilė, Egiptas, Ekvadoras, Ispanija, Kolumbija, Marokas, Meksikas, Peru, Prancūzija, Venesuela
Thrombostat	Turkija
Tirofiban	Ispanija, Vokietija
Tiroprest	Turkija
Welban	Ispanija
Xtraban	Indija

Bibliografija

Įpurškimas

Bibliografija : Tirofiban

	Tipas	Leidinys
1071	Žurnalas	Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA. Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets. Am J Health-Syst Pharm 1999 ; 56: 1627-1629.
1420	Žurnalas	Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M. Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration. J Clin Pharm Ther 1999 ; 24: 125-132.
1508	Žurnalas	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1512	Laboratorija	Tirofiban (Aggrastat®) - Summary of Product Characteristics Beacon Pharmaceuticals Ltd 2015
1600	Žurnalas	Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I. Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days. Am J Health-Syst Pharm 2001 ; 58: 1850-1851.
1603	Žurnalas	Bergquist PA, Manas D, Hunke WA, Reed RA. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs. Am J Health-Syst Pharm 2001 ; 58: 1218-1223.
1611	Žurnalas	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1713	Žurnalas	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
2004	Žurnalas	Patel K, Hursting MJ. Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 1381-1384.
3823	Žurnalas	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.

Mentions Légales